TK
Alpha Teknova, Inc.
TKNO · NASDAQ
$7.79 +6.13% (+$0.45)
1M +11.29%
Market Cap $399.4M
P/E Ratio -
Div. Yield -
ROE 24.94%
Piotroski F-Score Weak
3/9Valuation
10 /100
Expensive P/S 9.14x
P/B 6.38x
P/E N/A
Growth
12 /100
Declining Rev. growth 0.73%
Book val. growth 11.70%
EPS growth N/A
Profitability
13 /100
Weak Gross margin 33.94%
Net margin 38.37%
FCF margin 16.37%
Quality
6 /100
Poor ROIC 17.48%
ROE 24.94%
Asset turnover 0.46x
Debt
64 /100
Moderate Debt/Equity 0.44x
Current ratio 4.49x
Int. coverage -18.12x
Stability
83 /100
Stable Beta 0.73x
Rev. volatility 9.82%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre TKNO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Stephen Gunstream
Employees
158
Headquarters
Hollister
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report